Translational Session
Biomarkers and Modifiers of CKD and CKD Outcomes, Including the Jack W. Coburn, MD, Endowed Lectureship
October 22, 2026 | 10:30 AM - 12:30 PM
Location: Mile High Ballroom 1A, Convention Center
Session Description
The search for accurate biomarkers in CKD is challenging. Disease modifiers may interfere in an already complex landscape. This session focuses on factors that could improve the evaluation of disease outcomes and conditions that affect cardiovascular disease, mineral metabolism, and CKD risk. Particular attention is given to CKD stage, age, and sex in humans and animal models.
ASN gratefully acknowledges Amgen for support of the Coburn Endowed Lectureship.
Learning Objective(s)
- Articulate predictors of cardiovascular disease and mortality in CKD
- Discuss sex hormones as modifiers of fibroblast growth factor 23 (FGF-23)-induced cardiac outcomes
- Explain the importance of age on markers of mineral metabolism in CKD
- Develop strategies for CKD risk evaluation in the context of FGF-23 excess
Learning Pathway(s)
- Bones‚ Stones‚ and Mineral Metabolism
- CKD Non-Dialysis
Moderators
Presentations
- Predictors of Cardiovascular Disease and Mortality in CKD: The Jack W. Coburn, MD, Endowed Lectureship
10:30 AM - 11:00 AM
- Protective Role of Estrogen Against FGF-23-Induced Cardiac Hypertrophy
11:00 AM - 11:30 AM
- Markers of Mineral Metabolism in Children with CKD
11:30 AM - 12:00 PM
- Evaluation of CKD Risk in Hereditary Hypophosphatemic Rickets
12:00 PM - 12:30 PM